American Heart Journal
Volume 143, Issue 5 , Pages 748-752, May 2002

Enoxaparin in acute coronary syndromes: Evidence for superiority over placebo or untreated control☆☆☆★

London, Ontario, Canada

From the Department of Medicine, London Health Sciences Centre, University of Western Ontario

Received 3 May 2001; accepted 16 November 2001.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Guest editor for this manuscript was Carl J. Pepine, MD, University of Florida College of Medicine, Gainesville, Fla.

☆☆ Reprint requests: David Massel, MD, FRCPC, London Health Sciences Centre, Rm 205, Colborne Bldg, Victoria Campus, 375 South St, London, Ontario, Canada N6A 4G5.

★ E-mail: dmassel@lhsc.on.ca

PII: S0002-8703(02)40447-4

doi:10.1067/mhj.2002.121808

American Heart Journal
Volume 143, Issue 5 , Pages 748-752, May 2002

Article Tools

* Image Usage & Resolution